Bureau C, Thabut D, Jezequel C, Archambeaud I, et al. The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial. Ann Intern Med 2021 Feb 2. doi: 10.7326/M20-0202.
PMID: 33524293